Received: 16 April 2022
Accepted: 8 September 2022
First Online: 25 September 2022
: Prior to the commencement of the study, written informed consent was obtained from participants to receive convalescent plasma for treatment of their covid-19 infection. Ethical approval for publication of the study results was obtained from Dubai Scientific Research Ethics Committee (DSREC) of Dubai Health Authority (DHA) (Reference number:- DSREC-05/2021_14, dated 15 June 2021). All methods were carried out in accordance with relevant guidelines and regulations.
: No identifying data is included, so no consent for publication was required.
: The authors declare that there is no conflict of interest.